ライフサイエンスコーパス: MRI

1 MRI brain lesion distribution criteria were able to dist

2 MRI can also show any associated hematometra and endomet

3 MRI data were collected from all subjects and superficia

4 MRI detected 28 complete- and 12 partial-thickness tears

5 MRI features were the following: all lesions were hypoin

6 MRI in snapping scapula syndrome, which is a clinical di

7 MRI-guided pulsed focused ultrasound (pFUS) combined wit

8 MRI-visible perivascular space severity in either locati

9 Motor Neuron pattern was observed in 1 of 14 MRIs.

10 seropositivity, (2) myelitis attack and (3) MRI spinal cord demonstrating ring-enhancement.

11 s (2.23% +/- 0.68%) between generated and 4D MRI-extracted AMs were observed.

12 Twelve pre-surgical TLE patients (7 MRI-negative) and age-matched healthy volunteers were sc

13 On abdominal MRI, 2 patients had normal findings, one patient had col

14 omic landmarks on the generated and acquired MRI datasets.

15 ies evaluating the predictive value of acute MRI lesion patterns for discriminating clinical outcome

16 reat enthusiasm for clinical use of advanced MRI-guided radiotherapy systems.

17 Devices were interrogated before and after MRI with the use of a standardized protocol and were app

18 >50% change from baseline) immediately after MRI was a decrease in P-wave amplitude, which occurred i

19 CD generator could not be interrogated after MRI and required immediate replacement; the device had n

20 not affected during simultaneous aggressive MRI.

21 Although MRI appears to be the most sensitive modality for identi

22 ith MRET, we demonstrate the principle of an MRI-based ruler for nanometre-scale distance measurement

23 Using anatomical MRI optimized for myelin contrast within gray matter, we

24 tions in plasma correlated with clinical and MRI findings.

25 =0.537) for T stage between the clinical and MRI staging assessments.

26 pleen volume as determined by blinded CT and MRI at a central imaging laboratory).

27 ults from conventional abdominopelvic CT and MRI.

28 with ultrasound, sternal radiographs, CT and MRI.

29 Our results indicate that LCI and MRI may be useful complementary tools for noninvasive mo

30 LCI and MRI were sensitive to detect response to antibiotic ther

31 d by a board-certified neuroradiologist, and MRI reports were searched for the terms cavernous malfor

32 and thus is promising for biomedical NMR and MRI applications.

33 were scanned twice on an integrated PET and MRI scanner.

34 ementary information obtainable with PET and MRI.

35 a high-resolution [(18)F]FEPPA PET scan and MRI.

36 o behavioral abnormalities in both sexes and MRI-detected brain microstructural alterations, in studi

37 apted multiple breath washout techniques and MRI studies were performed in 97 clinically stable child

38 uded 50 patients referred for ultrasound and MRI because of shoulder pain.

39 erties and imaging them using ultrasound and MRI.

40 s urography, voiding cysto-urethrography and MRI of the abdomen.

41 is study is to assess the accuracy of US and MRI in diagnosing rotator cuff tears.

42 g rotator cuff tears on ultrasound (USG) and MRI.

43 ion known as the "molar tooth sign" on axial MRI.

44 he presence of hypodense veins on T2* -based MRI.

45 t find any morphological feature on baseline MRI that predicted later onset of ICB.

46 and to correlate these metrics with baseline MRI apparent diffusion coefficient (ADC) histogram metri

47 d for N stage was moderate (k=0.458) between MRI and histopathology staging assessments.

48 Histogram data was correlated between MRI methods in all patients and with histopathology and

49 r period using records of patients' biodata, MRI date, indication, findings and scan time, sources of

50 itary plasmacytoma, provided that whole-body MRI is unable to be performed, and to distinguish betwee

51 body X-ray (WBXR) is negative and whole-body MRI is unavailable.

52 In-utero BOLD MRI time series were acquired at 29 to 34 weeks gestatio

53 gait and balance assessment as well as brain MRI.

54 atlas and additional individual fetal brain MRI atlases for completely automatic multi-atlas segment

55 atic multi-atlas segmentation of fetal brain MRI.

56 assessed by blinded central review of brain MRI scans by the study neuroradiologist in the modified

57 imaging studies, including structural brain MRI, magnetoencephalography and transcranial magnetic st

58 and quantitative neuroimaging with 3-T brain MRI and optical coherence tomography.

59 30 age-matched healthy controls using brain MRI.

60 ume, surface area, and perimeter assessed by MRI at day 2 correlated with early time point plasma dru

61 sured and intestinal content was assessed by MRI before and at various time points after consumption

62 f episodes were asymptomatic and detected by MRI during routine follow-up.

63 he detection of bone lesions at diagnosis by MRI versus PET-CT.

64 gestion of a solid meal were investigated by MRI and (13)C-lactose-ureide breath test.

65 retention of the fat depot was monitored by MRI.

66 nd sex- matched nonobese control subjects by MRI and analyzed the T2 hyperintensity as a measure of H

67 may potentially improve tolerance of cardiac MRI and therefore allow to examine an even broader patie

68 astolic function were evaluated with cardiac MRI and normalized to body surface area.

69 All patients underwent CXR/MRI, CCT/MRI, and PET/CT on the same day.

70 ages based on PET/CT, but not CXR/MRI or CCT/MRI, were associated with significant differences in mor

71 PET/CT- and CE-MRI-based volume estimation yielded comparable results f

72 (68)Ga-DOTATATE PET/CT in comparison to CE-MRI performed at a higher sensitivity (98.5% vs. 53.7%)

73 Chemical Exchange Saturation Transfer (CEST) MRI is sensitive to dilute metabolites with exchangeable

74 eas U.S. guidelines preferably point to CHCT/MRI in patients with head and neck squamous cell carcino

75 ricular myocardial strain using a novel cine MRI based deformation registration algorithm (DRA) in a

76 them in vivo with high-resolution, clinical MRI.

77 To date, studies of functional connectivity MRI (fcMRI) in individuals with preclinical AD have reli

78 ith F(18)-AV1451 and functional connectivity MRI (fcMRI) in the context of amyloid-PET imaging.

79 cal advances toward real-time phase-contrast MRI, the current work analyzed directions, velocities, a

80 currently inaccessible through conventional MRI techniques.

81 xamination, a baseline brain and spinal cord MRI scan obtained less than 3 months from clinical onset

82 We coupled MRI-based E-field models with amplitude titrations of mo

83 onset to 'out of relapse' follow-up (current MRI) had highly significant (p<0.01) opposing effects on

84 Cancer stages based on PET/CT, but not CXR/MRI or CCT/MRI, were associated with significant differe

85 which European ones primarily recommend CXR/MRI, whereas U.S. guidelines preferably point to CHCT/MR

86 All patients underwent CXR/MRI, CCT/MRI, and PET/CT on the same day.

87 In combination with clinical data MRI has moderate prognostic accuracy in the evaluation o

88 ociation was similar across three breast DCE-MRI post-contrast sequences.

89 e spatiotemporal features extracted from DCE-MRI provided stronger radiomic correlation to MVD than t

90 e for delineation of tumor habitats from DCE-MRI was developed as a two-part process involving: (1) s

91 Dynamic contrast enhanced MRI (DCE-MRI) coupled with a pharmacokinetic model can detect and

92 ffusion tensor imaging (DTI) is a derivative MRI technique that can detect disruption of white matter

93 Diffusion MRI (dMRI) is the only noninvasive method for mapping wh

94 Diffusion MRI was used to assess WM microstructure and fluid shift

95 METHOD: Structural and diffusion MRI scans were acquired on a 3-T system from 26 chronic

96 hod to improve the construction of diffusion MRI templates in light of inter-subject differences.

97 Two distinct MRI patterns of spinal cord involvement were described a

98 ific multiparametric MRI consisting of Dixon MRI and proton-density-weighted ZTE MRI to directly synt

99 ly linked to gadolinium (Gd) exposure during MRI with contrast.

100 , or ventricular arrhythmias occurred during MRI.

101 In 6-8 weeks genioglossus EMG and dynamic MRI of the upper airway were performed before and after

102 a baseline axial T2*-weighted gradient echo MRI sequence allowing for CMB detection.

103 ovides a short explanation of these emerging MRI methods and outlines the promising initial results o

104 ave been performed to synthesize and enhance MRI contrast with nanoparticles.

105 Dynamic contrast enhanced MRI (DCE-MRI) coupled with a pharmacokinetic model can d

106 Contrast-enhanced MRI is typically used to follow treatment response and p

107 nts underwent contrast (gadolinium)-enhanced MRI.

108 USPIO-enhanced MRI is a novel approach to the identification of aortic

109 f enhancement in late gadolinium enhancement MRI done immediately after ablation to predict acute ede

110 with the BLI findings, which points to (19)F MRI as a reliable method with which to track ASCs after

111 ls detected by a clinically applicable (19)F MRI method correlated with the BLI findings, which point

112 of 58 patient charts having at least 1 fetal MRI were reviewed.

113 tive likelihood ratio (0.20 versus 0.37) for MRI over CT.

114 oved by the Food and Drug Administration for MRI scanning).

115 without oral route is the drug of choice for MRI sedation in children in our institution with a succe

116 Functional MRI was used pre-operatively to localize music processin

117 metric analyses on anatomical and functional MRI contain clinically valuable information.

118 etic stimulation with model-based functional MRI, we show that disrupting neural excitability in the

119 We applied a combined functional MRI-PET scanner to simultaneously probe mothers' dopamin

120 te task of emotional faces during functional MRI in 28 healthy adults, with final analyses based on 2

121 simultaneous PET scanning during functional MRI studies was performed with a spiral in-and-out gradi

122 bally described the events during functional MRI, producing unguided detailed descriptions lasting up

123 Here, functional MRI was used to identify the network of brain regions th

124 Employing a combination of functional MRI (fMRI) and positron emission tomography (PET), we in

125 Multivariate analyses of functional MRI data demonstrated that, while food value is represen

126 and graph theoretical analysis of functional MRI data in human patients with the laryngeal form of dy

127 's disease using an event-related functional MRI (fMRI) experiment design.

128 itative stability during a spiral functional MRI sequence.

129 ork, assessed using resting-state functional MRI (fMRI), to predict the onset of depression in adoles

130 ge multisite study, resting-state functional MRI data were examined in young children with T1D (n = 5

131 applied novel fetal resting-state functional MRI to measure brain function in 32 human fetuses in ute

132 controls underwent resting-state functional MRI, and functional connectivity of executive function-r

133 e avoidance task while undergoing functional MRI.

134 We used functional MRI to investigate the role of the cerebellum in perform

135 Using functional MRI, we investigated the effect of constraining gaze in

136 Using functional MRI, we show these social prediction errors correlate wi

137 affected, N=99) were scanned with functional MRI (fMRI) (N=85), magnetoencephalography (N=33), or bot

138 Furthermore, MRI-based estimates of Gd-DTPA transport across these ba

139 One patient had MRI imaging but not CT; 5 had CSF pressure measurements.

140 However, MRI-based imaging studies have shown that white matter,

141 results illustrate the use of hyperpolarized MRI as a sensitive technique to monitor drug-induced per

142 monitored using magnetic resonance imaging (MRI) and (18)F-fluordeoxyglucose positron emission tomog

143 ninvasively with magnetic resonance imaging (MRI) and abnormalities in regional CBF are present in ma

144 Integration of magnetic resonance imaging (MRI) and other imaging modalities is promising to furnis

145 nanoplatform for magnetic resonance imaging (MRI) and x-ray computed tomography (CT) enabled by the g

146 rtening agent in magnetic resonance imaging (MRI) applications, but these techniques are limited by t

147 t are visible on magnetic resonance imaging (MRI) are a neuroimaging marker of cerebral small vessel

148 ography (CT) and magnetic resonance imaging (MRI) are both used for noninvasive diagnosis of hepatoce

149 es for improving magnetic resonance imaging (MRI) assessments, the underlying neural mechanisms of Mn

150 n and changes on magnetic resonance imaging (MRI) at 6 months and 24 months (change in lesion volume

151 Multiparametric Magnetic Resonance Imaging (MRI) can provide detailed information of the physical ch

152 Injectable Magnetic Resonance Imaging (MRI) contrast agents have been widely used to provide cr

153 is of functional magnetic resonance imaging (MRI) data by delineating regions of interest over which

154 l and functional magnetic resonance imaging (MRI) data, we aimed to identify these mPFC subareas in h

155 Magnetic resonance imaging (MRI) does not offer sufficient resolution to discriminat

156 Presentation of magnetic resonance imaging (MRI) findings in pregnant women in the Department of Dia

157 Magnetic resonance imaging (MRI) has been used for many years for anatomic evaluatio

158 In particular, magnetic resonance imaging (MRI) is critical for visualizing soft tissue and organs,

159 spaces (PVSs) on magnetic resonance imaging (MRI) is hypothesized to represent impaired drainage of i

160 iously linked to magnetic resonance imaging (MRI) manifestations of cerebrovascular disease, such as

161 diseases, where magnetic resonance imaging (MRI) may be non-contributory.

162 ssing speed with magnetic resonance imaging (MRI) measures of white and grey matter in a large popula

163 as a functional magnetic resonance imaging (MRI) phantom for sodium multi quantum (MQ) spectroscopy.

164 graphy (PET) and magnetic resonance imaging (MRI) scans acquired in a total of 210 healthy individual

165 1-weighted brain magnetic resonance imaging (MRI) scans from 2148 MDD patients and 7957 healthy contr

166 a pretransplant magnetic resonance imaging (MRI) severity score of less than 10 (scale range, 0-34;

167 CKGROUND & AIMS: Magnetic resonance imaging (MRI) techniques and ultrasound-based transient elastogra

168 used structural magnetic resonance imaging (MRI) to compare 103 children and adolescents with TS to

169 high-resolution magnetic resonance imaging (MRI) to estimate NAc volumes.

170 maging (PAI) and magnetic resonance imaging (MRI)) to detect melanin induction in SKMEL28 human melan

171 graphy (CT), and magnetic resonance imaging (MRI), which revealed bilateral bulky solid adnexal masse

172 ents with recent magnetic resonance imaging (MRI)-documented lacunar infarcts were randomly assigned

173 e performance of magnetic resonance imaging (MRI).

174 mography (CT) or magnetic resonance imaging (MRI).

175 characterized by magnetic resonance imaging (MRI).

176 st for molecular magnetic resonance imaging (MRI).

177 Advances in MRI and serological and genetic testing have greatly inc

178 Changes in MRI features and peak breath hydrogen levels were simila

179 d use these sulci to delineate mPFC areas in MRIs.

180 In a high proportion of infants, MRI detects punctate white matter lesions that are not s

181 occurring in glioma patients, can influence MRI findings.

182 This nanoparticle complex and its MRI T1-enhancing properties open the door for future stu

183 rkers may also find wide use in cell lineage MRI studies.

184 tudy population based solely on longitudinal MRI data.

185 metal ions; as nonlinear optical materials, MRI contrasting agents, and sensitizers for photodynamic

186 soft tissue and organs, with over 60 million MRI procedures performed each year worldwide.

187 Multi-modal MRI techniques have identified biomarkers that could hel

188 Using longitudinal multi-modal MRI, we monitored hippocampal injury and tissue reorgani

189 Future molecular MRI targeting P-selectin may be used to improve diagnosi

190 ometric parameters measured using multimodal MRI.

191 on after ICH can be assessed with multimodal MRI, and that perihaematomal vasogenic oedema might be a

192 Multiparametric MRI of the prostate gland is a relatively new diagnostic

193 of (18)F-choline PET/CT and multiparametric MRI were 56% and 74%, respectively.

194 T, (18)F-choline PET/CT, and multiparametric MRI within 15 d of each other.

195 bined (18)F-fluciclovine PET/multiparametric MRI show potential for detection and characterization of

196 the use of patient-specific multiparametric MRI consisting of Dixon MRI and proton-density-weighted

197 Whole-body muscle MRI offers a new approach to objective assessment of den

198 rdioverter-defibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved by the Food and Dru

199 tical cerebral microinfarcts (CMIs), a novel MRI marker of cerebral vascular disease, have not been s

200 rare, this case highlights the advantage of MRI over CT in identifying early changes in the internal

201 ging technology, the clinical application of MRI in the care of PSC patients and imaging standards va

202 Comparison of MRI findings between groups and correlation between clin

203 evidence that the anatomical distribution of MRI-visible perivascular spaces may reflect the underlyi

204 A retrospective review of MRI images of patients with metastatic UM to the liver a

205 ven healthy controls underwent 2 sessions of MRI for reproducibility study.

206 action with accuracy comparable with that of MRI.

207 The prognostic value of MRI biomarkers was assessed by retrospective correlation

208 ntensity and persistent active discopathy on MRI at 12 months and spine-specific limitations in activ

209 nicotine, and varenicline were tested for on MRI contrasts that captured reward sensitivity and cogni

210 = 3.0-5.9) white matter hyperintensities on MRI were independently associated with CMBs.

211 Muscle involvement on MRI is consistent in patients with LGMD2C-F and can be h

212 who had measurable lymphadenopathy by CT or MRI and disease progression within 36 months since their

213 propriate MPD diameter on preoperative CT or MRI to predict malignant disease was determined using a

214 bidimensionally measurable disease (by CT or MRI); life expectancy of 6 months or more; adequate haem

215 tive findings on conventional imaging (CT or MRI, and a (99m)Tc-methylene diphosphonate bone scan) be

216 tive imaging is best for CT-indeterminate or MRI-indeterminate liver nodules in patients with cirrhos

217 al/We retrospectively reviewed 69 paediatric MRI sedations performed over a 5-year period using recor

218 Pelvic MRI and CT images are interchangeable in retrospective m

219 )F-FMISO) PET and conventional and perfusion MRI before surgery.

220 Diffusion and perfusion MRI, and transcranial magnetic stimulation were used to

221 occurrence of categorized artifacts by 2 PET/MRI-experienced physicians.

222 mor tissue correlated between FMT/CT and PET/MRI.

223 Series of whole-body PET/MRI examinations were acquired for up to 3 h after injec

224 tional and anatomic images from combined PET/MRI systems.

225 The feasibility of (18)F-FDG PET/MRI for diagnosing pain generators in chronic sciatica w

226 Whole-body (18)F-FDG PET/MRI scans were obtained for 12 patients after PET/CT sca

227 d using an integrated 3-T time-of-flight PET/MRI system.

228 tenuation-correction (AC) approaches for PET/MRI in clinical neurooncology.

229 nesis and radiomic imaging features from PET/MRI.

230 (18)F-NaF PET/MRI was also performed in 46 patients.

231 Forty-nine PET/MRI brain scans were included: brain tumor studies using

232 ng a time-of-flight-enabled simultaneous PET/MRI scanner.

233 All subjects tolerated the PET/MRI examination well, and no adverse reactions to (18)F-

234 l-known sources of error associated with PET/MRI examinations, lead to inconsistent SUV measurements

235 s a significant association of pretransplant MRI severity and baseline verbal comprehension (r = -0.3

236 hod, we aligned 45 pairs of in vivo prostate MRI and corresponding ex vivo histopathology images.

237 These findings are useful since provide MRI-based indications of possible subtending connectivit

238 oposed method can be generalized to quantify MRI data where SNR is suboptimal.

239 d a strong relationship between quantitative MRI relaxation times and hepatic iron content.

240 resolution (800 mum isotropic), quantitative MRI technique to better elucidate the neuroanatomical un

241 Repeat MRI was not associated with an increase in adverse event

242 g orthotopic breast tumors for in vivo SPECT/MRI and biodistribution studies after injection with (17

243 erum of patients with MS to brain and spinal MRI.

244 rmed diffusion tensor imaging and structural MRI, polysomnography, and neuropsychological assessments

245 ing electroencephalography (EEG), structural MRI, and sleep-dependent memory assessment, we addressed

246 (37 PwCIS, 32 PwMS) and 36 HS underwent 3 T MRI including 3-dimensional T1-weighted MRIs.

247 est cardiac diseases with CMIs graded on 3-T MRI in a memory clinic population.

248 r up to two weeks post injection using 9.4 T MRI.

249 To clearly distinguish the PVSs in the 7 T MRI, we propose a novel PVS enhancement method based on

250 A recent quantitative clinically-targeted MRI method, fast macromolecular proton fraction (MPF) ma

251 ssess potential characteristics for targeted MRI contrast agents, including high relaxivity, unapprec

252 and modified on the MGN surface for targeted MRI detection.

253 Here, we use a novel 7 Tesla MRI glutamate imaging technique (GluCEST) to estimate ch

254 enase in mice using a preclinical 11.7 Tesla MRI system.

255 However, US is more specific than MRI in detecting PTT.

256 The MRI growth patterns were classified as nodular or diffus

257 opriately programmed per protocol before the MRI.

258 ated apparatus nearby but separated from the MRI magnet.

259 ed via simulation prior to deployment in the MRI scanner.

260 and complexity of such investigation in the MRI scanner.

261 However, understanding the MRI enhancement mechanism in a multishell nanoparticle g

262 ic (PA) imaging emerged as an alternative to MRI and X-ray tomography in biomedical imaging, due to i

263 nd Memory in Elders cohort who had undergone MRI of the brain (n = 296; mean +/- SD age: 73 +/- 8.1 y

264 rt B) included 16 MDD patients who underwent MRI at baseline then 24 h following intravenous infusion

265 l center between 2012 and 2014 who underwent MRI with ASL.

266 CMI grading (none, incomplete, or ungradable MRI), leaving a sample size of 243 for final analysis (m

267 Using MRI, we compared brain structure, function, and connecti

268 four individuals each scanned 24 times using MRI.

269 (SM) mass and selected organs over 2 y using MRI in overweight adults with type 2 diabetes.

270 Quantitative histological and in vivo MRI assessments of non-heme cellular iron revealed that

271 rther analysis of 102 hemispheres of in vivo MRI scans (N = 51 males, mean +/- SD 24.1 +/- 3.1 years

272 ation of cerebral microinfarcts with in-vivo MRI are provided to support further studies of the assoc

273 ation of the baseline T1-weighted volumetric MRI.

274 Perfusion-weighted or diffusion-weighted MRI is a widely applicable clinical tool, and the "misma

275 Diffusion-weighted MRI was the most useful readily available test to classi

276 T2-weighted MRI, diffusion-weighted MRI, and PET features were the most important for classi

277 umber of new lesions enhanced on T1-weighted MRI ["enhancing lesions"], and cumulative combined numbe

278 vidual sites analysed structural T1-weighted MRI brain scans with harmonised protocols of individuals

279 tform that takes in preprocessed T1-weighted MRI data and outputs volume, surface, and tabular data c

280 We also show that T1-weighted MRI images acquired immediately after contrast injection

281 esions [new enhancing lesions on T1-weighted MRI plus new and newly enlarged lesions on T2-weighted M

282 orphometry, based on ante-mortem T1-weighted MRI, was used to identify cross-sectional group differen

283 Using gadolinium-enhanced T1-weighted MRI, we determined that vascular permeability is not hom

284 have desirable properties for T2 - weighted MRI, with bone marrow-derived primary human mesenchymal

285 agents for stem cell tracking by T2-weighted MRI as they are biocompatible and show no evidence of cy

286 ule as observed on pre-treatment T2-weighted MRI between prostate cancer patients who do (BCR (+)) an

287 nths (change in lesion volume on T2-weighted MRI, cumulative number of new lesions enhanced on T1-wei

288 T2-weighted MRI, diffusion-weighted MRI, and PET features were the m

289 ew and newly enlarged lesions on T2-weighted MRI]).

290 3 T MRI including 3-dimensional T1-weighted MRIs.

291 MDCTF can be utilized when MRI is contraindicated or not feasible.

292 etailed physical examination following which MRI was carried out on Philips Gyroscan Achieva 1.5 Tesl

293 istry to determine the risks associated with MRI at a magnetic field strength of 1.5 tesla for patien

294 [TTPmin]) were evaluated and correlated with MRI parameters (maximal lesion diameter, volume of contr

295 ascade of events is ultimately detected with MRI using magnetic interaction between target and water

296 ography can be non-invasively evaluated with MRI.

297 ET/CT versus conventional brain imaging with MRI.

298 ifferences, and we compared the results with MRI measures of gray matter (GM) atrophy.

299 esent predominantly (in 4/5 patients) within MRI contrast-enhanced areas, although (89)Zr-bevacizumab

300 of Dixon MRI and proton-density-weighted ZTE MRI to directly synthesize pseudo-CT images with a deep